ASX
NeuroScientific Biopharmaceuticals Ltd
NSB:ASX•Healthcare
Sensitive ASX Announcement
First Subject Recruited for Early-Phase Clinical Trial
Published: 30/06/22, 10:07am (AEST)•2 pages